1. Home
  2. SONN vs SGLY Comparison

SONN vs SGLY Comparison

Compare SONN & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • SGLY
  • Stock Information
  • Founded
  • SONN N/A
  • SGLY 2001
  • Country
  • SONN United States
  • SGLY United States
  • Employees
  • SONN N/A
  • SGLY N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • SONN Health Care
  • SGLY
  • Exchange
  • SONN Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • SONN 3.8M
  • SGLY 4.4M
  • IPO Year
  • SONN N/A
  • SGLY 2008
  • Fundamental
  • Price
  • SONN $3.99
  • SGLY $1.07
  • Analyst Decision
  • SONN Strong Buy
  • SGLY
  • Analyst Count
  • SONN 1
  • SGLY 0
  • Target Price
  • SONN $20.00
  • SGLY N/A
  • AVG Volume (30 Days)
  • SONN 11.6M
  • SGLY 42.6K
  • Earning Date
  • SONN 08-13-2025
  • SGLY 08-26-2025
  • Dividend Yield
  • SONN N/A
  • SGLY N/A
  • EPS Growth
  • SONN N/A
  • SGLY N/A
  • EPS
  • SONN N/A
  • SGLY N/A
  • Revenue
  • SONN $1,000,000.00
  • SGLY $2,172,036.00
  • Revenue This Year
  • SONN $5,376.22
  • SGLY N/A
  • Revenue Next Year
  • SONN N/A
  • SGLY N/A
  • P/E Ratio
  • SONN N/A
  • SGLY N/A
  • Revenue Growth
  • SONN 978.39
  • SGLY N/A
  • 52 Week Low
  • SONN $1.08
  • SGLY $0.54
  • 52 Week High
  • SONN $19.30
  • SGLY $7.65
  • Technical
  • Relative Strength Index (RSI)
  • SONN 47.24
  • SGLY 53.38
  • Support Level
  • SONN $4.16
  • SGLY $0.99
  • Resistance Level
  • SONN $19.30
  • SGLY $1.14
  • Average True Range (ATR)
  • SONN 1.98
  • SGLY 0.05
  • MACD
  • SONN -0.41
  • SGLY 0.00
  • Stochastic Oscillator
  • SONN 1.03
  • SGLY 66.67

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: